Allergic reactions to the Pfizer COVID-19 vaccine are higher than expected

Pfizer COVID-19 vaccine is causing allergic reactions at a rate that is higher than what one might expect from other shots, says lead science advisor for Operation Warp Speed

  • Dr Moncef Slaoui said the last time he was updated on allergic reactions was on Tuesday, when six cases occurred.
  • “That frequency, as it was yesterday, is higher than what would be expected with other vaccines,” he said.
  • There are discussions between vaccine manufacturers and the National Institutes of Health to consider conducting clinical trials of vaccines in highly allergic groups
  • A potential study could look at vaccines made by Pfizer and Moderna, although the reactions have only been reported by people who received the Pfizer injection

The chief scientific advisor for Operation Warp Speed ​​said on Wednesday that Pfizer’s COVID-19 vaccine is causing more allergic reactions than those typical of other vaccines.

Dr Moncef Slaoui said the last time he was updated on allergic reactions was on Tuesday, when there were six cases, CNN reported.

“That frequency, as it was yesterday, is higher than what would be expected with other vaccines,” he said.

Dr Moncef Slaoui said the last time he was updated on allergic reactions was on Tuesday, when six cases of allergic reactions occurred.

Dr Slaoui noted that coronavirus vaccination data lags behind actual numbers.

He added that there are discussions between vaccine manufacturers and the National Institutes of Health to consider running clinical trials of the vaccines in highly allergic populations, ideally those who carry an EpiPen.

Taking the test could help figure out what’s causing the allergic reactions, Dr. Slaoui said.

On Monday, an official from the National Institute of Allergy and Infectious Diseases told CNBC that the United States is looking into why people have experienced severe allergic reactions after taking the COVID-19 vaccine.

There are discussions between vaccine manufacturers and the National Institutes of Health to consider conducting clinical trials of vaccines in highly allergic groups

There are discussions between vaccine manufacturers and the National Institutes of Health to consider conducting clinical trials of vaccines in highly allergic groups

A study is currently in the early stages of planning and is expected to include “several hundred” of people who have a history of severe allergic reactions, according to Alkis Togias, head of the NIAID’s Department of Allergy, Asthma and Airway Biology.

His department will lead the study, which will hopefully begin in the coming weeks.

The study could look at vaccines made by Pfizer and Moderna, although the reactions have only been reported by people who received the Pfizer injection.

A New York City health worker has become the sixth known person to suffer from a “severe” allergic reaction to a COVID-19 vaccine.

Two British health care workers experienced anaphylactic shock when they received it in the first week of its administration and three in Alaska also experienced similar reactions.

More than 30,000 COVID-19 vaccines have been distributed in New York City and are the only people known to have had a reaction.

Source